A novel vaccine targeting Fusobacterium nucleatum against abscesses and halitosis.

[1]  L. Kocgozlu,et al.  Prevalence of periodontal pathogens in subgingival lesions, atherosclerotic plaques and healthy blood vessels: a preliminary study. , 2008, Journal of periodontal research.

[2]  K. Okuda,et al.  Stimulation of Fusobacterium nucleatum biofilm formation by Porphyromonas gingivalis. , 2007, Oral microbiology and immunology.

[3]  B. Karthikeyan,et al.  Vaccination against periodontitis: the saga continues , 2007, Expert review of vaccines.

[4]  P. Moore,et al.  Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK‐NF‐κB pathway , 2007, Journal of leukocyte biology.

[5]  D. Tang,et al.  Topical Application of Escherichia coli-Vectored Vaccine as a Simple Method for Eliciting Protective Immunity , 2006, Infection and Immunity.

[6]  Hyun-chul Lee,et al.  Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. , 2006, Journal of clinical periodontology.

[7]  M. Tufano,et al.  Neutrophil function in rapidly progressive and adult periodontitis , 2006, European Journal of Epidemiology.

[8]  Jumpei Washio,et al.  Hydrogen sulfide-producing bacteria in tongue biofilm and their relationship with oral malodour. , 2005, Journal of medical microbiology.

[9]  J. Hearst,et al.  Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity , 2005, Nature Medicine.

[10]  E. Weiss,et al.  Fluorescence based measurements of Fusobacterium nucleatum coaggregation and of fusobacterial attachment to mammalian cells. , 2005, FEMS microbiology letters.

[11]  G. Seymour,et al.  Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model. , 2004, Oral microbiology and immunology.

[12]  Yiping W Han,et al.  Fusobacterium nucleatum Induces Premature and Term Stillbirths in Pregnant Mice: Implication of Oral Bacteria in Preterm Birth , 2004, Infection and Immunity.

[13]  J. Liebana,et al.  Periodontal diseases: microbiological considerations. , 2004, Medicina oral, patologia oral y cirugia bucal.

[14]  Armando Garcia,et al.  Minibioreactor-gas collector for determining bacteria-produced hydrogen sulfide , 2003 .

[15]  D. Hinode,et al.  Relationship between tongue coating and secretory-immunoglobulin A level in saliva obtained from patients complaining of oral malodor. , 2003, Journal of clinical periodontology.

[16]  Modelling oral malodour in a longitudinal study. , 2003, Archives of oral biology.

[17]  Y. Kawamura,et al.  Use of micro gas chromatography in the fuel cycle of fusion reactors , 2003 .

[18]  J. Nicoli,et al.  Cytokine production in response to endodontic infection in germ-free mice. , 2002, Oral microbiology and immunology.

[19]  Robert J. Palmer,et al.  Communication among Oral Bacteria , 2002, Microbiology and Molecular Biology Reviews.

[20]  H. Fukamachi,et al.  3‐Chloro‐DL‐alanine resistance by L‐methionine‐α‐deamino‐γ‐mercaptomethane‐lyase activity , 2002 .

[21]  D J Smith,et al.  Dental caries vaccines: prospects and concerns. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[22]  J. Mcghee,et al.  A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. , 2002, Vaccine.

[23]  Y. Shimazaki,et al.  Immunization against dental caries. , 2002, Vaccine.

[24]  G. Seymour,et al.  Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model , 2002, Clinical and experimental immunology.

[25]  H. Fukamachi,et al.  3-Chloro-DL-alanine resistance by L-methionine-alpha-deamino-gamma-mercaptomethane-lyase activity. , 2002, FEBS letters.

[26]  M. A. Borrello,et al.  Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis. , 2000, Oral microbiology and immunology.

[27]  G L Roberts,et al.  Fusobacterial infections: an underestimated threat. , 2000, British journal of biomedical science.

[28]  C. Desloovere,et al.  [Halitosis--foetor ex ore]. , 1998, Laryngo- rhino- otologie.

[29]  J. Holmgren,et al.  Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine. , 1998, Vaccine.

[30]  S. Wåler,et al.  On the transformation of sulfur-containing amino acids and peptides to volatile sulfur compounds (VSC) in the human mouth. , 1997, European journal of oral sciences.

[31]  B. Shenker,et al.  Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle , 1995, Infection and immunity.

[32]  K. Yaegaki,et al.  Volatile sulfur compounds in mouth air from clinically healthy subjects and patients with periodontal disease. , 1992, Journal of periodontal research.

[33]  J. P. Smith,et al.  Accumulation of plasma cells in inflamed sites: effects of antigen, nonspecific microbial activators, and chronic inflammation , 1991, Infection and immunity.

[34]  T. Hofstad,et al.  Outer membrane proteins as major antigens of Fusobacterium nucleatum. , 1989, FEMS microbiology immunology.

[35]  J. Thompson,et al.  Amino acid-dependent transport of sugars by Fusobacterium nucleatum ATCC 10953 , 1987, Journal of bacteriology.

[36]  H. Yoshie,et al.  Effects of a Fusobacterium nucleatum Extract on Immunoregulation in Mice , 1985, Journal of dental research.

[37]  K. Okuda,et al.  Immunoglobulin G response to subgingival gram-negative bacteria in human subjects , 1984, Infection and immunity.

[38]  A. González,et al.  [Microbiological aspects of halitosis and its treatment]. , 1983, Revista ADM : organo oficial de la Asociacion Dental Mexicana.

[39]  M. Aono,et al.  Adjuvant effects of oral microorganisms on the immunological responses. , 1974, Archives of oral biology.

[40]  J. Tonzetich Direct gas chromatographic analysis of sulphur compounds in mouth air in man. , 1971, Archives of oral biology.